We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KW:NYSEKennedy-Wilson Holdings Inc. Analysis

Data as of 2026-05-22 - not real-time

$11.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

KW is trading at $11, just above its 20‑day SMA of $10.96 and 50‑day SMA of $10.92, indicating short‑term bullish momentum. The 200‑day SMA sits at $9.64, providing a strong long‑term floor. RSI at 57 and a bullish MACD crossover (+0.0005 histogram) reinforce the upward bias. Volume is rising, and the stock holds above the identified support of $10.87 while facing resistance near $11.09. The Fear & Greed Index reads “Extreme Greed” at 91, suggesting market enthusiasm may be peaking. However, the upside/downside projection is –18%, hinting at limited upside.
On the fundamentals side, revenue slipped 0.8% to $541.5 M, and operating cash flow turned negative at –$24.6 M. The company’s gross margin remains robust at 74.7% and operating margin at 15.5%, yet free cash flow is –$22.4 M. Debt is a major red flag: total debt of $4.85 B translates to a debt‑to‑equity of 312, dwarfing its $189.7 M cash pile. The trailing P/E of 91.7 and forward P/E of –10.3 signal severe overvaluation relative to earnings. Dividend yield appears attractive at 4.36%, but a payout ratio of 400% makes the dividend clearly unsustainable. Combined with a modest ROE of 5% and negative forward EPS, the fundamentals weigh heavily against the technical optimism.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Technical price near resistance
  • High valuation (P/E 91)
  • Unsustainable dividend payout

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Debt refinancing risk
  • Potential dividend cut
  • Support level at $10.87

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Massive leverage
  • Negative cash flow
  • Overvaluation relative to earnings

Key Metrics & Analysis

Financial Health

Revenue Growth-0.80%
Profit Margin10.93%
P/E Ratio91.7
ROE4.95%
ROA0.83%
Debt/Equity312.16
P/B Ratio2.0
Op. Cash Flow$-24600000
Free Cash Flow$-22425000
Industry P/E32.6

Technical Analysis

TrendBullish
RSI57.4
Support$10.87
Resistance$11.09
MA 20$10.96
MA 50$10.92
MA 200$9.64
MACDBullish
VolumeIncreasing
Fear & Greed Index91.38

Valuation

Target Price$9.00
Upside/Downside-18.18%
GradeOvervalued
TypeValue
Dividend Yield4.36%

Risk Assessment

Beta0.48
Volatility3.42%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.